Muhammad Ikram

5.5k total citations · 3 hit papers
63 papers, 2.9k citations indexed

About

Muhammad Ikram is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Muhammad Ikram has authored 63 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 14 papers in Physiology and 12 papers in Neurology. Recurrent topics in Muhammad Ikram's work include Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Alzheimer's disease research and treatments (10 papers) and Tryptophan and brain disorders (10 papers). Muhammad Ikram is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Alzheimer's disease research and treatments (10 papers) and Tryptophan and brain disorders (10 papers). Muhammad Ikram collaborates with scholars based in South Korea, Netherlands and Pakistan. Muhammad Ikram's co-authors include Myeong Ok Kim, Amjad Khan, Tahir Ali, Shafiq Ur Rehman, Tahir Muhammad, Muhammad Sohail Khan, Sayed Ibrar Alam, Tae Ju Park, Jong Ryeal Hahm and Sareer Ahmad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Muhammad Ikram

58 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease

2017 388 citations Tahir Ali, Shafiq Ur Rehman et al. Molecular Neurobiology profile →
Objectives, design and main findings until 2020 from the Rotterdam Study

2020 316 citations M. Arfan Ikram, Guy Brusselle et al. European Journal of Epidemiology profile →
The Rotterdam Study. Design update and major findings between 2020 and 2024

2024 54 citations M. Arfan Ikram, Brenda C.T. Kieboom et al. European Journal of Epidemiology profile →

Peers

Countries citing papers authored by Muhammad Ikram

Since Specialization

Citations

This map shows the geographic impact of Muhammad Ikram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Ikram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Ikram more than expected).

Fields of papers citing papers by Muhammad Ikram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Ikram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Ikram. The network helps show where Muhammad Ikram may publish in the future.

Co-authorship network of co-authors of Muhammad Ikram

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Ikram. A scholar is included among the top collaborators of Muhammad Ikram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Ikram. Muhammad Ikram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diels-Alder reaction: A versatile synthetic tool for the synthesis of terpenoids and alkaloids: A review 2025 ·Tetrahedron ·Muhammad Ikram, Asim Mansha, Samreen Gul Khan, Ameer Fawad Zahoor, Muhammad Naveed Anjum, (unknown), (unknown), Aijaz Rasool Chaudhry, Ahmad Irfan, Muhammad Nadeem Abbas	0
2	Ratios in regression analyses with causal questions 2024 ·American Journal of Epidemiology ·Sanne S. Mooldijk, Jeremy A. Labrecque, M. Arfan Ikram, Muhammad Ikram	2
3	Burden of cardiometabolic disorders and lifetime risk of new-onset atrial fibrillation among men and women: the Rotterdam Study 2024 ·European Journal of Preventive Cardiology ·(unknown), (unknown), Martijn J. Tilly, (unknown), (unknown), Muhammad Ikram, Natasja M.S. de Groot, Maryam Kavousi	7
4	Burden of intracranial artery calcification in white patients with ischemic stroke 2024 ·European Stroke Journal ·(unknown), (unknown), Dianne H.K. van Dam-Nolen, Aad van der Lugt, Marleen de Bruijne, Peter J. Koudstaal, Muhammad Ikram, Daniël Bos	5
5	Long‐term exposure to non‐steroidal anti‐inflammatory (NSAID) medication in relation to dementia risk: a population‐based cohort study 2024 ·Alzheimer s & Dementia ·(unknown), Bruno H. Stricker, Muhammad Ikram, Frank J. Wolters, M. Arfan Ikram	1
6	The Rotterdam Study. Design update and major findings between 2020 and 2024 breakdown → 2024 ·European Journal of Epidemiology ·M. Arfan Ikram, Brenda C.T. Kieboom, Willem Pieter Brouwer, Guy Brusselle, Layal Chaker, Mohsen Ghanbari, André Goedegebure, Muhammad Ikram, Maryam Kavousi, Robert J. de Knegt, Annemarie I. Luik, Joyce B. J. van Meurs, Luba M. Pardo, Fernando Rivadeneira, Frank J.A. van Rooij, Meike W. Vernooij, Trudy Voortman, Natalie Terzikhan	54
7	Brain artery diameters and risk of dementia and stroke 2024 ·Alzheimer s & Dementia ·Jesús D. Melgarejo, (unknown), (unknown), Minghua Liu, (unknown), Stephanie Assuras, Bonnie Levin, Mitchell S.V. Elkind, Muhammad Ikram, Maryam Kavousi, M. Arfan Ikram, Clinton B. Wright, Fabrice Crivello, (unknown), Christophe Tzourio, Meike W. Vernooij, Tatjana Rundek, Zhen‐Yu Zhang, Daniël Bos, José Gutierrez	4
8	Skin autofluorescence, reflecting accumulation of advanced glycation end products, and the risk of dementia in a population-based cohort 2024 ·Scientific Reports ·Sanne S. Mooldijk, (unknown), (unknown), Jinluan Chen, Meike W. Vernooij, Muhammad Ikram, M. Carola Zillikens, M. Arfan Ikram	9
9	No association between blood-based markers of immune system and migraine status: a population-based cohort study 2023 ·BMC Neurology ·(unknown), Rikje Ruiter, Daniël Bos, Muhammad Ikram	3
10	Association of GABRG2 rs211037 Gene Polymorphism With Epilepsies and Pharmacoresistance to Anti-Epileptic Drugs; A Meta-Analysis 2023 ·Shakir Ullah, (unknown), (unknown), Muhammad Zakria, (unknown), Muhammad Ikram	1
11	Updates on the Role of Probiotics against Different Health Issues: Focus on Lactobacillus 2022 ·International Journal of Molecular Sciences ·(unknown), Amjad Khan, Muhammad Zakria, Sami Siraj, Shakir Ullah, Muhammad Khalid Tipu, Muhammad Ikram, Myeong Ok Kim	37
12	6-Methoxyflavone and Donepezil Behavioral Plus Neurochemical Correlates in Reversing Chronic Ethanol and Withdrawal Induced Cognitive Impairment 2022 ·Drug Design Development and Therapy ·(unknown), Khalid Rauf, (unknown), (unknown), Muhammad Ikram, Robert D. E. Sewell	7
13	Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes‐Mediated Alzheimer’s Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin 2021 ·Oxidative Medicine and Cellular Longevity ·Muhammad Sohail Khan, Muhammad Ikram, Tae Ju Park, Myeong Ok Kim	30
14	Objectives, design and main findings until 2020 from the Rotterdam Study breakdown → 2020 ·European Journal of Epidemiology ·M. Arfan Ikram, Guy Brusselle, Mohsen Ghanbari, André Goedegebure, Muhammad Ikram, Maryam Kavousi, Brenda C.T. Kieboom, Caroline C. W. Klaver, Robert J. de Knegt, Annemarie I. Luik, Tamar Nijsten, Robin P. Peeters, Frank J.A. van Rooij, Bruno H. Stricker, André G. Uitterlinden, Meike W. Vernooij, Trudy Voortman	316
15	Caffeine Modulates Cadmium-Induced Oxidative Stress, Neuroinflammation, and Cognitive Impairments by Regulating Nrf-2/HO-1 In Vivo and In Vitro 2019 ·Journal of Clinical Medicine ·Amjad Khan, Muhammad Ikram, Tahir Muhammad, Junsung Park, Myeong Ok Kim	119
16	COMPLICATIONS DURING HEMODIALYSIS IN END STAGE RENAL DISEASE PATIENTS IN A TEACHING HOSPITAL 2019 ·Journal of Postgraduate Medical Institute ·(unknown), Muhammad Abdur Rahman Afridi, (unknown), Muhammad Ikram, (unknown)	2
17	Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse Model 2019 ·Molecular Neurobiology ·Muhammad Ikram, Tahir Muhammad, Shafiq Ur Rehman, Amjad Khan, Min Gi Jo, Tahir Ali, (unknown)	150
18	Practice and attitude on household waste management in Tumpat and Kuala Krai, Kelantan 2018 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Muhammad Ikram, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	5
19	Neuroprotective Effect of Quercetin Against the Detrimental Effects of LPS in the Adult Mouse Brain 2018 ·Frontiers in Pharmacology ·Amjad Khan, Tahir Ali, Shafiq Ur Rehman, Muhammad Sohail Khan, Sayed Ibrar Alam, Muhammad Ikram, Tahir Muhammad, Kamran Saeed, Haroon Badshah, Myeong Ok Kim	199
20	Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model 2018 ·Journal of Neuroimmune Pharmacology ·Tahir Muhammad, Tahir Ali, Muhammad Ikram, Amjad Khan, Sayed Ibrar Alam, Myeong Ok Kim	165

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact